Literature DB >> 29087392

Putting Evidence into Practice: IBD Surveillance, Chromoendoscopy and Future Directions.

J R Ten Hove1, C N Bernstein2,3, B Oldenburg1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29087392     DOI： 10.1038/ajg.2017.390

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  15 in total

Review 1.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

Authors:  Stuart R Cairns; John H Scholefield; Robert J Steele; Malcolm G Dunlop; Huw J W Thomas; Gareth D Evans; Jayne A Eaden; Matthew D Rutter; Wendy P Atkin; Brian P Saunders; Anneke Lucassen; Paul Jenkins; Peter D Fairclough; Christopher R J Woodhouse
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

2.  AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Authors:  Francis A Farraye; Robert D Odze; Jayne Eaden; Steven H Itzkowitz; Robert P McCabe; Themistocles Dassopoulos; James D Lewis; Thomas A Ullman; Tom James; Robin McLeod; Lawrence J Burgart; John Allen; Joel V Brill
Journal:  Gastroenterology       Date:  2010-02       Impact factor: 22.682

3.  SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.

Authors:  Loren Laine; Tonya Kaltenbach; Alan Barkun; Kenneth R McQuaid; Venkataraman Subramanian; Roy Soetikno
Journal:  Gastroenterology       Date:  2015-03       Impact factor: 22.682

4.  Fecal calprotectin testing can identify ineffective colorectal cancer surveillance procedures in patients with longstanding colitis.

Authors:  Erik Mooiweer; Herma H Fidder; Peter D Siersema; Robert J F Laheij; Bas Oldenburg
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

Review 5.  Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials.

Authors:  Andrea Iannone; Marinella Ruospo; Germaine Wong; Mariabeatrice Principi; Michele Barone; Giovanni F M Strippoli; Alfredo Di Leo
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-25       Impact factor: 11.382

6.  Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance.

Authors:  Erik Mooiweer; Andrea E van der Meulen-de Jong; Cyriel Y Ponsioen; C Janneke van der Woude; Ad A van Bodegraven; Jeroen M Jansen; Nofel Mahmmod; Willemijn Kremer; Peter D Siersema; Bas Oldenburg
Journal:  Clin Gastroenterol Hepatol       Date:  2015-05-06       Impact factor: 11.382

7.  Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer.

Authors:  Toshiaki Watanabe; Yoichi Ajioka; Keiichi Mitsuyama; Kenji Watanabe; Hiroyuki Hanai; Hiroshi Nakase; Reiko Kunisaki; Keiji Matsuda; Ryuichi Iwakiri; Nobuyuki Hida; Shinji Tanaka; Yoshiaki Takeuchi; Kazuo Ohtsuka; Kazunari Murakami; Kiyonori Kobayashi; Yasushi Iwao; Masakazu Nagahori; Bunei Iizuka; Keisuke Hata; Masahiro Igarashi; Ichiro Hirata; Shin-Ei Kudo; Takayuki Matsumoto; Fumiaki Ueno; Gen Watanabe; Masahiro Ikegami; Yoko Ito; Koji Oba; Eisuke Inoue; Naoki Tomotsugu; Toru Takebayashi; Kenichi Sugihara; Yasuo Suzuki; Mamoru Watanabe; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2016-08-12       Impact factor: 22.682

8.  Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.

Authors:  Sabela Carballal; Sandra Maisterra; Antonio López-Serrano; Antonio Z Gimeno-García; María Isabel Vera; José Carlos Marín-Garbriel; José Díaz-Tasende; Lucía Márquez; Marco Antonio Álvarez; Luis Hernández; Luisa De Castro; Jordi Gordillo; Ignasi Puig; Pablo Vega; Marco Bustamante-Balén; Juan Acevedo; Beatriz Peñas; María López-Cerón; Elena Ricart; Miriam Cuatrecasas; Mireya Jimeno; María Pellisé
Journal:  Gut       Date:  2016-09-09       Impact factor: 23.059

9.  Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease.

Authors:  M W M D Lutgens; B Oldenburg; P D Siersema; A A van Bodegraven; G Dijkstra; D W Hommes; D J de Jong; P C F Stokkers; C J van der Woude; F P Vleggaar
Journal:  Br J Cancer       Date:  2009-10-13       Impact factor: 7.640

10.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.

Authors:  Fernando Magro; Paolo Gionchetti; Rami Eliakim; Sandro Ardizzone; Alessandro Armuzzi; Manuel Barreiro-de Acosta; Johan Burisch; Krisztina B Gecse; Ailsa L Hart; Pieter Hindryckx; Cord Langner; Jimmy K Limdi; Gianluca Pellino; Edyta Zagórowicz; Tim Raine; Marcus Harbord; Florian Rieder
Journal:  J Crohns Colitis       Date:  2017-06-01       Impact factor: 10.020
View more
  2 in total

1.  Dysplasia Surveillance in Inflammatory Bowel Disease: A Cohort Study.

Authors:  Sofia Saraiva; Isadora Rosa; Joana Moleiro; João Pereira da Silva; Ricardo Fonseca; António Dias Pereira
Journal:  GE Port J Gastroenterol       Date:  2020-10-19

Review 2.  Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question.

Authors:  Roberto Gabbiadini; Ferdinando D'Amico; Alessandro De Marco; Maria Terrin; Alessandra Zilli; Federica Furfaro; Mariangela Allocca; Gionata Fiorino; Silvio Danese
Journal:  J Clin Med       Date:  2022-01-20       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.